Abstract: Provided herein are compositions and method to treat a subject for a dental pulp injury, disease or disorder or to regenerate dental pulp.

Abstract: A technology is described for a wide-band radio frequency amplifier using cross-over diplexers. A first port is configured to receive RF signals in a wide-band RF spectrum. A cross-over diplexer splitter is coupled to the first port. The cross-over diplexer splitter is configured to filter the RF signals in the wide-band RF spectrum into a low frequency (LF) signal having an LF pass-band and a high frequency (HF) signal having an HF pass-band with the LF pass-band crossing the HF pass-band at a cross-over frequency. An HF RF amplifier is configured to amplify the HF signal to form an amplified HF signal. An LF RF amplifier configured to amplify the LF signal to form an amplified LF signal. A cross-over diplexer combiner is configured to combine the amplified HF signal and the amplified LF signal and output amplified RF signals in the wide-band RF spectrum.

Abstract: A technology is described for a repeater that is switchable between a duplex mode and a simplex mode. The repeater comprises a first antenna port coupled to a first antenna, a second antenna port coupled to a second antenna, and a third antenna port coupled to a third antenna. The repeater further comprises first direction amplification paths coupled between the first antenna port and the second antenna port and second direction amplification paths coupled between the first antenna port and one of the second antenna port and the third antenna port. A controller can switch the repeater between a duplex mode, to communicate a first-direction RF signal from the second antenna port and communicate a second-direction RF signal to the second antenna port, and a simplex mode, to communicate the first-direction RF signal from the second antenna port and communicate the second-direction RF signal to the third antenna port.

Abstract: Compositions comprising a reverse-temperature sensitive hydrogel comprising a biopolymer such as a polysaccharide and a synthetic polymer, and a compound in an amount that reversibly inhibits respiratory enzyme complex I, and methods of using the composition, are provided.

Abstract: Compositions comprising nanoparticles, nanoplexes or virus comprising isolated nucleic acid comprising nucleic acid encoding a mammalian, and methods of using the compositions, are provided.

Abstract: A method to prevent, inhibit or treat intervertebral disc disease in a mammal and compositions useful in that regard are provided.

Abstract: In certain embodiments, the present invention provides a method for preventing or treating post-traumatic osteoarthritis (PTOA) in the temporomandibular joint (TMJ) in a subject in need thereof, comprising administrating a pharmaceutical composition comprising an effective amount of mesenchymal stem cell-derived exosomes or mesenchymal stem cell-derived exosomal microRNA to the subject. In certain embodiments, the present invention provides a method for preventing progressive fibrocartilage degeneration in a subject in need thereof, comprising administrating a pharmaceutical composition comprising an effective amount of mesenchymal stem cell-derived exosomes or mesenchymal stem cell-derived exosomal microRNA to the subject.

Abstract: Compositions comprising a reverse-temperature sensitive hydrogel comprising a biopolymer such as a polysaccharide and a synthetic polymer, and a compound in an amount that reversibly inhibits respiratory enzyme complex I, and methods of using the composition, are provided.

Abstract: Compositions comprising a reverse-temperature sensitive hydrogel comprising a biopolymer such as a polysaccharide and a synthetic polymer, and a compound in an amount that reversibly inhibits respiratory enzyme complex I, and methods of using the composition, are provided.

Abstract: Compositions comprising a reverse-temperature sensitive hydrogel comprising a biopolymer such as a polysaccharide and a synthetic polymer, and a compound in an amount that reversibly inhibits respiratory enzyme complex I, and methods of using the composition, are provided.

Abstract: Therapeutic methods and compositions for treating fibrosis (e.g. scarring) are provided, as well as compositions comprising blebbistatin or a salt thereof and PLGA and nanoparticles comprising blebbistatin or a salt thereof and PLGA.

Abstract: Compositions comprising a reverse-temperature sensitive hydrogel comprising a biopolymer such as a polysaccharide and a synthetic polymer, and a compound in an amount that reversibly inhibits respiratory enzyme complex I, and methods of using the composition, are provided.

Abstract: Aspects of the present invention provide a solution for reducing cycle time of automatically created spreadsheets. Specifically, an embodiment of the present invention provides a way to create a spreadsheet from data that is in a native format more quickly and/or efficiently. To do so, the invention accesses a control file using optimized settings to create the spreadsheet. Then, after creation of the spreadsheet, the invention uses a second control file having the final settings to modify the spreadsheet in preparation for output. The invention may use agents to perform all or a portion of these activities.

Abstract: Disclosed are a method, system and computer program for collecting inventory data about a group of machines at an office. This method comprises the steps of running an inventory tool on each of the machines, and the tool presenting dialog displays on each of the machines, filling in or changing data in the dialogs presented by the tool, and submitting the collected information to a server. Also disclosed are a method, system and computer program for customizing an inventory data collection tool for a plurality of logical groups of users. Each of the logical groups of users is provided with a copy of the inventory data collection tool and with a first copy of a common control file. Each of the groups of users uses the first copy of the common control file to customize the tool for the group of users.

Abstract: Aspects of the present invention provide a solution for reducing cycle time of automatically created spreadsheets. Specifically, an embodiment of the present invention provides a way to create a spreadsheet from data that is in a native format more quickly and/or efficiently. To do so, the invention accesses a control file using optimized settings to create the spreadsheet. Then, after creation of the spreadsheet, the invention uses a second control file having the final settings to modify the spreadsheet in preparation for output. The invention may use agents to perform all or a portion of these activities.

Abstract: A pharmaceutical composition is provided that is useful to enhance the repair of articular cartilage, to treat a joint injury or to prevent, inhibit or treat osteoarthritis in a mammal. The composition may include an effective amount of an isolated protein that is a chemoattractant for chondrogenic progenitor cells and/or an effective amount of an isolated protein that is a chondro genic factor or a nucleic acid sequence that encodes a chondrogenic factor.

Abstract: A method, system and program product for performing one or more actions in response to a change made to a key data field in a project management application for managing a project. The method includes establishing one or more metrics to be monitored for a project, defining one or more actions for at least one key data field of a plurality of key data fields in the project management application, the one or more actions being defined in accordance with a level of control to be exercised and being triggered by one or more pre-specified conditions associated with the one or more metrics monitored for the project. The method further includes automatically performing at least one action of the one or more actions in response to a relative impact to the project caused by a change made to the at least one key data field.

Abstract: Processes for manufacture and assembly of implantable medical devices are described. In particular, techniques are provided for nondestructive electrical isolation assessment of feedthrough assemblies of the implantable medical devices. The feedthrough assemblies may include an insulating structure, a plurality of terminal pins extending through the insulator and a ferrule having an inner lumen into which the insulating structure is disposed. One or more insulating seals may be disposed at the interface of the ferrule-to-insulating structure and/or the terminal pin-to-insulating structure. The electrical isolation assessments may be based on the dielectric properties of the components of the feedthrough assemblies, such as the insulating structure.

Abstract: Therapeutic methods and compositions for treating fibrosis (e.g. scarring) are provided, as well as compositions comprising blebbistatin or a salt thereof and PLGA and nanoparticles comprising blebbistatin or a salt thereof and PLGA.

Abstract: An assembly that has a rotator element, a sensor element coupled to the rotator element or assembly, and a controller element provides azimuth antenna control. The rotator element has a worm gear driven stewing ring having a through hole through which a feed line to an antenna may be inserted to accommodate continuous rotation of greater than 360 degrees or partial rotation in either direction of the antenna coupled to the rotator element. The controller element is coupled to the rotator element and to the sensor element, and the controller element receives feedback information concerning a current azimuth position of the antenna from the sensor element to control the rotator element to rotate to a future azimuth position of the antenna in accordance with a selected azimuth function and the feedback information provided by the sensor element.